Cervical Cancer and Cervical Dysplasia: Symptoms, Diagnosis, Treatment & Complications

Cervical dysplasia is the abnormal, precancerous change of cells on the cervix caused by a persistent high-risk HPV infection; cervical cancer is what those changes can become if they aren't caught and treated. Most HPV clears on its own, but the small share that lingers can drive dysplasia over years. Screening finds these changes long before cancer develops.

The essentials: how HPV becomes dysplasia, and dysplasia becomes cancer

HPV is the most common STI, and it's the root cause of nearly all cervical disease CDC, About HPV. The virus comes in two functional camps people constantly blur together. Low-risk types (6 and 11) cause genital warts; high-risk types (16, 18, and several others) cause cancers. The types that cause warts do not cause cancer, and the types that cause cancer don't cause warts, so warts are not a sign you're heading toward cervical cancer.

In most cases — about nine out of ten — HPV goes away on its own within two years with no health problems, cleared by your immune system before it can do harm. Cervical disease comes from the minority of infections that persist. When a high-risk type sticks around in the cells of the cervix, it can switch on changes that make those cells grow abnormally. That abnormal growth is dysplasia (also called CIN, cervical intraepithelial neoplasia). Dysplasia is graded from mild to severe. Mild changes often regress on their own, but moderate-to-severe changes are the precancer that, left alone over years, can become invasive cervical cancer.

This whole process is slow and silent, so screening works well. HPV's reach goes well beyond the cervix. It causes virtually all cervical cancer, over 90% of anal cancers, and about 70% of throat (oropharyngeal) cancers, and oropharyngeal cancer has now overtaken cervical as the most common HPV-related cancer in the US NCI, HPV and Cancer. The full list of HPV-driven cancers includes cervical, vulvar, vaginal, penile, and anal cancers, plus cancer in the back of the throat.

Symptoms: why early dysplasia feels like nothing

Most high-risk HPV infections are asymptomatic and produce no clinical disease, and cervical dysplasia itself causes no symptoms at all. You cannot feel precancerous cells. By the time symptoms appear, disease is usually more advanced. A normal exam and feeling fine are not substitutes for screening.

Symptoms that should prompt a clinician visit, especially in someone overdue for screening, include abnormal vaginal bleeding (between periods, after sex, or after menopause), unusual or persistent vaginal discharge, and pelvic pain or pain during sex. Many benign conditions cause these too, but they warrant evaluation rather than waiting.

Don't confuse warts with cancer warning signs. Genital warts usually appear as a small bump or group of bumps in the genital area, caused by the low-risk types. They can be a nuisance, but they are not precancerous and they don't turn into cervical cancer.

Testing: screening is the whole game

Because dysplasia is silent, screening is how it's found. Current guidance starts cervical screening at age 25 with a primary HPV test every five years as the preferred approach, rather than a yearly Pap ACS Screening Guidelines. Most HPV clears within two years, so testing for the virus itself catches more precancer while sparing people unnecessary annual visits. Co-testing (HPV plus Pap together) and Pap alone at shorter intervals remain acceptable alternatives.

The screening tests do different jobs. The HPV test looks for the high-risk virus in cervical cells; the Pap (cytology) looks for the abnormal cells themselves. A positive HPV test or an abnormal Pap typically leads to colposcopy — an in-office exam where the clinician views the cervix under magnification and takes a small biopsy of any suspicious area. The biopsy is what diagnoses and grades dysplasia. Sample collection feels like a routine pelvic exam; a biopsy can cause a brief pinch or cramp.

A few testing realities trip people up. There is no routine HPV test for men — HPV tests aren't recommended to screen men, adolescents, or women under age 30, and for women HPV is found through cervical screening, not a general STD panel. A standard panel won't tell you your HPV status. HPV testing also isn't used to diagnose warts; the result doesn't confirm them or change how they're treated. If you're sorting out timing around a recent exposure or a partner's diagnosis, see when to test after exposure, and you can get tested for the STIs that do show up on panels.

What about anal screening?

CDC's 2021 guidance found the data insufficient to recommend routine anal cytology, even for men who have sex with men or people with HIV CDC STI Treatment Guidelines. That position predates the 2022 ANCHOR trial, which showed treating high-grade anal lesions reduced anal cancer in people with HIV. Since then, some specialty groups (such as IDSA/HIVMA) suggest periodic anal Pap for high-risk groups where high-resolution anoscopy referral exists, but it's not a blanket CDC recommendation. If you're in a higher-risk group, see the deeper rundown on the anal pap smear.

Treatment: dysplasia and warts are managed completely differently

Treating cervical dysplasia means removing or destroying the abnormal cells before they can progress, and it's handled separately from anything to do with warts. Mild changes are often just monitored, since many regress on their own. Moderate-to-severe dysplasia is usually treated with an in-office procedure — most commonly LEEP (loop electrosurgical excision), which uses a thin heated wire to remove the affected zone, or cryotherapy/ablation. These are short procedures, typically with local anesthesia and a recovery measured in a few weeks of avoiding sex and tampons. Treating precancer is highly effective and prevents cancer.

There is no antiviral that cures HPV itself. The immune system clears the virus in most people; treatment targets the cells. Cervical cancer that has already developed is managed by oncology with surgery, radiation, and/or chemotherapy depending on stage — beyond the scope of screening but very treatable when caught early.

Genital warts (a separate, low-risk problem)

Genital warts are managed apart from dysplasia and aren't a cancer concern. A clinic freezes them or you apply a prescription cream at home over weeks, and none is clearly better than another. Patient-applied options include imiquimod 3.75% or 5% cream, podofilox 0.5% solution or gel, and sinecatechins 15% ointment (sinecatechins aren't recommended for immunocompromised or HIV-positive patients). Provider-administered options include cryotherapy with liquid nitrogen, TCA or BCA 80%–90% solution, and surgical removal by excision, curettage, laser, or electrosurgery. Treating warts doesn't remove the virus, so they can recur.

Prevention: the vaccine plus screening do the heavy lifting

Prevention rests on three pillars: vaccination, cervical screening, and condoms (which give only partial protection, because HPV can infect skin a condom doesn't cover). The vaccine is the standout. Given at the recommended ages, it can prevent more than 90% of HPV-caused cancers, and Gardasil 9 is about 98% effective against the precancers caused by HPV 16 and 18 ACS, HPV Vaccination.

The vaccine used in the US today is Gardasil 9, which protects against nine types: 6, 11, 16, 18, 31, 33, 45, 52, and 58 CDC Pink Book. Types 16 and 18 alone cause about 66% of cervical cancers; the five additional high-risk types in Gardasil 9 cause about another 15%; and types 6 and 11 cause more than 90% of genital warts. The earlier quadrivalent Gardasil covered four types and bivalent Cervarix covered two, but since 2016 only Gardasil 9 has been distributed here, so it guards against more cancer-causing types than the older shots.

The vaccine is prevention, not treatment. Gardasil 9 protects against future infection but won't clear an HPV infection or warts you already have, and vaccinated people still need cervical screening, because no vaccine covers every high-risk type. If you're weighing the shot, here's a plain look at the hpv vaccine side effects and the broader question, is the gardasil hpv vaccine safe?

When to see a clinician

• You're due or overdue for cervical screening — the single most important action, even with no symptoms.
• You have abnormal bleeding (between periods, after sex, or after menopause), new persistent discharge, or pelvic pain.
• You got an abnormal Pap or positive HPV result and need follow-up colposcopy or treatment.
• You have genital bumps you want evaluated and treated.
• You want the HPV vaccine, or aren't sure whether you completed the series.